AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · Connecticut

SB00855

An Act Concerning Funding For The Psychedelic-assisted Therapy Pilot Program.

Status

Did not pass; died when the session ended

2025 Session

IntroducedJan 22, 2025 (done)
PassedDid not happen (skipped)
SignedDid not happen (skipped)
Law in effectDid not happen (skipped)

Sponsor: Martha Marx (Democrat)
Type: Appropriations / Administrative
Substances: Psilocybin

Official text

Summary (from PoliPsy)

To appropriate funding for the psychedelic-assisted therapy pilot program.

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: cga.ct.gov

Legislative history

January 22, 2025
Referred
January 22, 2025
Referred
January 22, 2025
Introduced

Loading bill…